Drugs / liquid piobacteriophage complex
liquid piobacteriophage complex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04682964 | Oct 2020 → Dec 2025 overdue | acute tonsillitis | Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan | Active not recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liquid piobacteriophage complex | “The patients received bacteriophage therapy with a liquid piobacteriophage complex (liquid pyobacteriophage complex - PCL).” NCT04682964 ↗ |
| Known as | liquid pyobacteriophage complex | “The patients received bacteriophage therapy with a liquid piobacteriophage complex (liquid pyobacteriophage complex - PCL).” NCT04682964 ↗ |
| Known as | pyobacteriophage complex liquid | “Bacteriophage therapy using a liquid complex of pyobacteriophages (pyobacteriophage complex liquid - PСL).” NCT04682964 ↗ |
| Known as | PСL | “Bacteriophage therapy using a liquid complex of pyobacteriophages (pyobacteriophage complex liquid - PСL).” NCT04682964 ↗ |
| Route | Inhaled | “PСL was administered via nebulizer inhalation to irrigate the mucous membranes of the tonsils.” NCT04682964 ↗ |